Annual CFF
$41.95 M
-$125.14 M-74.89%
December 31, 2023
Summary
- As of February 7, 2025, TERN annual cash flow from financing activities is $41.95 million, with the most recent change of -$125.14 million (-74.89%) on December 31, 2023.
- During the last 3 years, TERN annual CFF has fallen by -$43.56 million (-50.94%).
- TERN annual CFF is now -74.89% below its all-time high of $167.09 million, reached on December 31, 2022.
Performance
TERN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$163.29 M
+$162.89 M+40825.31%
September 30, 2024
Summary
- As of February 7, 2025, TERN quarterly cash flow from financing activities is $163.29 million, with the most recent change of +$162.89 million (+40825.31%) on September 30, 2024.
- Over the past year, TERN quarterly CFF has increased by +$149.43 million (+1077.98%).
- TERN quarterly CFF is now at all-time high.
Performance
TERN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$177.55 M
+$163.27 M+1143.28%
September 30, 2024
Summary
- As of February 7, 2025, TERN TTM cash flow from financing activities is $177.55 million, with the most recent change of +$163.27 million (+1143.28%) on September 30, 2024.
- Over the past year, TERN TTM CFF has increased by +$135.60 million (+323.24%).
- TERN TTM CFF is now -19.56% below its all-time high of $220.72 million, reached on March 31, 2021.
Performance
TERN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
TERN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -74.9% | +1078.0% | +323.2% |
| 3 y3 years | -50.9% | +1078.0% | +323.2% |
| 5 y5 years | -58.0% | +1078.0% | +323.2% |
TERN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -74.9% | at low | at high | -100.0% | -9.0% | >+9999.0% |
| 5 y | 5-year | -74.9% | >+9999.0% | at high | >+9999.0% | -19.6% | >+9999.0% |
| alltime | all time | -74.9% | >+9999.0% | at high | >+9999.0% | -19.6% | >+9999.0% |
Terns Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $163.29 M(>+9900.0%) | $177.55 M(+1143.3%) |
| Jun 2024 | - | $399.00 K(>+9900.0%) | $14.28 M(-0.6%) |
| Mar 2024 | - | $0.00(-100.0%) | $14.37 M(-65.7%) |
| Dec 2023 | $41.95 M(-74.9%) | $13.86 M(>+9900.0%) | $41.95 M(-68.7%) |
| Sep 2023 | - | $20.00 K(-95.9%) | $134.06 M(-31.3%) |
| Jun 2023 | - | $489.00 K(-98.2%) | $195.04 M(+0.2%) |
| Mar 2023 | - | $27.58 M(-74.0%) | $194.68 M(+16.5%) |
| Dec 2022 | $167.09 M | $105.97 M(+73.7%) | $167.09 M(+173.3%) |
| Sep 2022 | - | $61.00 M(>+9900.0%) | $61.14 M(+6425.2%) |
| Jun 2022 | - | $124.00 K(>+9900.0%) | $937.00 K(-220.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $0.00(-100.0%) | -$776.00 K(-100.6%) |
| Dec 2021 | $134.39 M(+57.2%) | $16.00 K(-98.0%) | $134.39 M(-33.8%) |
| Sep 2021 | - | $797.00 K(-150.2%) | $203.02 M(+0.4%) |
| Jun 2021 | - | -$1.59 M(-101.2%) | $202.25 M(-8.4%) |
| Mar 2021 | - | $135.17 M(+96.9%) | $220.72 M(+158.1%) |
| Dec 2020 | $85.52 M(>+9900.0%) | $68.64 M(>+9900.0%) | $85.52 M(+406.8%) |
| Sep 2020 | - | $32.00 K(-99.8%) | $16.88 M(+0.2%) |
| Jun 2020 | - | $16.88 M(<-9900.0%) | $16.84 M(<-9900.0%) |
| Mar 2020 | - | -$33.00 K | -$33.00 K |
| Dec 2019 | $62.00 K(-99.9%) | - | - |
| Dec 2018 | $99.76 M | - | - |
FAQ
- What is Terns Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals annual CFF year-on-year change?
- What is Terns Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals quarterly CFF year-on-year change?
- What is Terns Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Terns Pharmaceuticals?
- What is Terns Pharmaceuticals TTM CFF year-on-year change?
What is Terns Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of TERN is $41.95 M
What is the all time high annual CFF for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high annual cash flow from financing activities is $167.09 M
What is Terns Pharmaceuticals annual CFF year-on-year change?
Over the past year, TERN annual cash flow from financing activities has changed by -$125.14 M (-74.89%)
What is Terns Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of TERN is $163.29 M
What is the all time high quarterly CFF for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high quarterly cash flow from financing activities is $163.29 M
What is Terns Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, TERN quarterly cash flow from financing activities has changed by +$149.43 M (+1077.98%)
What is Terns Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of TERN is $177.55 M
What is the all time high TTM CFF for Terns Pharmaceuticals?
Terns Pharmaceuticals all-time high TTM cash flow from financing activities is $220.72 M
What is Terns Pharmaceuticals TTM CFF year-on-year change?
Over the past year, TERN TTM cash flow from financing activities has changed by +$135.60 M (+323.24%)